Similarly, spatial single-cell studies in colorectal cancer revealed that enrichment of FAP+ fibroblasts and SPP1+ macrophages correlate with reduced benefit from anti-PD-L1 therapy, underscoring the immunosuppressive crosstalk between stromal and myeloid compartments [222]. The gene discussed is FAP; the disease is colorectal cancer.